SkyQuest Technology Group recently introduced Digital Pathology Market study with in-depth overview, describing about the Product/Industry Scope and elaborates market outlook and status (2025-2032). The market Study is segmented by key regions which is accelerating the marketization. The Digital Pathology Market has witnessed Excellent growth over the past decade and is expected to maintain its upward trajectory.
Digital Pathology Market size was valued at USD 1133.61 Million in 2023 and is poised to grow from USD 1222.03 Million in 2024 to USD 2228.61 Million by 2032, growing at a CAGR of 7.8% during the forecast period (2025-2032)
A computer-enabled image-based information platform called “digital pathology” aids in the administration of data produced from digital slides. The rise in cancer incidence, the need for precise diagnosis, and the creation of innovative digital pathology systems by numerous significant players are the main factors propelling the growth of the global digital pathology market Size. A survey released by Medscape suggests that a higher death rate may be linked to chronic illnesses. The increased frequency of cardiovascular illnesses is the primary driver behind the development of sophisticated diagnostic tools. Therefore, the requirement for digital pathology systems grows along with the development of chronic and cardiovascular diseases, propelling the growth of the digital pathology market.
Get a Free Sample PDF of the Report – https://www.skyquestt.com/sample-request/digital-pathology-market
Technology in digital pathology can benefit a research pipeline in two ways. The first is that macroscopic photographs, tissue microarrays, and whole slide images can be arranged using the designated file storage and viewing software. The creation and use of image analysis methods is the second way that digital pathology is used in research. Additionally, government financing, the expanding use of telepathology solutions in drug development and companion diagnostics, as well as the growing demand for telepathology solutions, which enable pathologists to assess cases remotely and consult worldwide in real-time, are the primary drivers of digital pathology market expansion.
Digital Pathology Market Segments Analysis:
Global Digital Pathology Market is segmented based on product, application, and region.
Based on product, the market is segmented into Software {by type [integrated and standalone (information management system and image analysis software)], by deployment mode (on premises and cloud based), scanners (brightfield scanners and other scanners), device, and storage systems. By application, the market is segmented into drug discovery & development, academic research, and disease diagnosis. By type, the market is segmented into human pathology and veterinary pathology. By end use it is segmented into pharmaceutical and biotechnology, Hospitals & Reference Laboratories, Academic & Research Institutes. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Digital Pathology Market Regional Insights:
Due to its highly developed healthcare systems, sophisticated technology uptake and substantial investment in research and development, North America is the global leader in digital pathology. The region has an abundance of top-notch tech firms and an ecosystem which encourages growths in digital pathology innovations. Also, the North American healthcare services are directed towards enhancing accuracy in diagnosis as well as efficiency; thus, fueling the need for these digital solutions. Government support for healthcare IT advancements, coupled with the growing prevalence of chronic diseases, further fuels digital pathology market growth, positioning North America as a leader in the digital pathology sector.
Top Market Players in Digital Pathology Market are:
Philips Healthcare (Netherlands)
Roche Diagnostics (Switzerland)
Hamamatsu Photonics (Japan)
3DHISTECH (Hungary)
GE Healthcare (US)
Apollo Enterprise Imaging (US)
Olympus Corporation (Japan)
Mikroscan Technologies (US)
Inspirata (US)
PerkinElmer (US)
Huron Digital Pathology (Canada)
Sectra AB (Sweden)
PathAI (US)
Indica Labs (US)
F. Hoffmann-La Roche (Switzerland)
Nikon Corporation (Japan)
Danaher Corporation (US)
Visiopharm (Denmark)
Densitas (Canada)
Objective Pathology (US)
QPath (US)
Digital Pathology Market Recent Developments:
In August 2024, the next-generation digital pathology platform from Philips Healthcare was recently launched, the Philips IntelliSite Pathology Solution 3.0. The upgrade improves image quality and integrates artificial intelligence algorithms to support diagnosis with greater accuracy. The new platform seeks to enhance global pathologist workflow efficiency and diagnostic precision.
In July 2024, Leica Biosystems is releasing its new product, Aperio GT 450 Scanner. Its unique selling point is that it has better speed and resolution as compared to other such scanners present in the market. The ultra-modern scanner can scan many slides in a very short time and has improved image clarity. It has been meant for simplifying the pathology processes and facilitate the performance of advanced diagnoses.
In June 2024, In June 2024 Nikon Instruments launched DPA-NIS a new digital pathology imaging system. The system provides high resolution images and has seamless integration with AI based diagnostic tools. By enabling accurate and high-quality digital images for analysis, it is set to improve pathology research and clinical diagnostics.
Also Read –
https://en.everybodywiki.com/Digital_Pathology
https://vinitsawant.hatenablog.com/entry/2025/03/28/202707?_gl=1*itko1j*_gcl_au*NzA0MzAyMjA2LjE3NDI5MDgxOTA.
Forward-Looking Insights
The Digital Pathology Market is set to experience sustained growth, fueled by technological advancements, broader global market access, and rising industry demand. With the industry addressing emerging challenges and capitalizing on new opportunities, it is expected to drive innovation and play a pivotal role in advancing global health and economic progress.
About Company:
SkyQuest is an IP focused Research and Investment Bank and Accelerator of Technology and assets. We provide access to technologies, markets and finance across sectors viz. Life Sciences, CleanTech, AgriTech, NanoTech and Information & Communication Technology.
We work closely with innovators, inventors, innovation seekers, entrepreneurs, companies and investors alike in leveraging external sources of R&D. Moreover, we help them in optimizing the economic potential of their intellectual assets. Our experiences with innovation management and commercialization have expanded our reach across North America, Europe, ASEAN and Asia Pacific.
Contact Details:
SkyQuest Technology Group
USA (+1) 351-333-4748
Email: [email protected]
